Emerson Electric EMR

NYSE · Electronic & Other Electrical Equipment (No Computer Equip) · $88.8B
$162.00+1.79%Nov 18 close · Databento
Every report since 2023 →
TradingView’s own chart and price feed. The page’s numbers are end-of-day closes.

Data provided by Databento (end of day). Next close = the first close after a story against the close before it; official daily closes only, not a call, not advice.

The numbers

fiscal 2026, as filed with the SEC · 66-metric EOD snapshot via Databento
Market cap$88.8B
EV / True FCF30.3x
Revenue$19.0B +5.4%
True FCF (ex-SBC)$3.3B +32.5%
Rule of 4024.0%
True FCF Yield3.7%
EPS, diluted$4.79 +19.8%
Modern Valuation (EOD)
Market Cap$88.8B
Enterprise Value$99.9B
EV / True FCF30.29
EV / FCF28.26
EV / Gross Profit9.86
EV / EBIT—
EV / Sales5.26
P / E (GAAP)32.99
P / FCF25.11
P / Oper. CF22.32
P / Book4.28
Owner & Cash Yields
True FCF Yield3.7%
FCF Yield4.0%
Owner Earn. Yield3.9%
Earnings Yield3.0%
Shareholder Yield+2.3%
Buyback Yield1.1%
Dividend Yield1.37%
Dividend / sh$2.22
Payout Ratio46%
FCF / sh$6.44
EPS (diluted)$4.79
Compounder & Returns
Rule of 4024.0%
ROIC—
Cash ROIC (CROIC)11.1%
GP / Assets24.2%
ROE13.0%
ROA6.4%
Gross Margin53.4%
Oper. Margin—
Net Margin14.2%
FCF Margin18.6%
True FCF Margin17.4%
Quality & Dilution
Cash Conversion131%
Accrual Ratio−3.1%
SBC % of FCF6.7%
SBC % of Rev1.2%
Reinvest. Rate32%
Sales Growth Y/Y+5.4%
Sales 3Y CAGR+7.8%
EPS Growth Y/Y+19.8%
FCF Growth Y/Y+32.5%
FCF 3Y CAGR+134.5%
Share Change Y/Y−0.8%
Balance Sheet & Scale
Revenue (FY)$19.0B
Gross Profit (FY)$10.1B
Oper. Income (FY)—
GAAP Net Income$2.7B
True FCF (ex-SBC)$3.3B
Cash & Equiv$1.8B
Total Debt$12.9B
Net Cash (Debt)$-11.1B
Net Cash % MCap−12.5%
Debt / FCF (yrs)3.7y
Current Ratio0.94548.60M sh
Price & Technicals (EOD)
Perf Week−3.03%
Perf Month+0.96%
Perf Quarter+4.71%
Perf Half Y+21.93%
Perf YTD+19.59%
SMA 20 Dist−1.82%$165.01
SMA 50 Dist+1.19%$160.09
SMA 100 Dist+4.57%$154.92
Window High−5.12%$170.74
Window Low+24.00%$130.65
RSI (14) · Vol47.835%v
Income Distribution & Cash Flow ConversionHow every dollar of EMR revenue flows through cost of goods, operating expenses, taxes, GAAP net income, and dilution-adjusted free cash flow
REVENUE · 100%$19.0BGROSS PROFIT · 53.4%$10.1BCOST OF REV · 46.6%$8.9BOPER. INCOME · 53.4%$10.1BNET INCOME · 14.2%$2.7BTAX & OTHER · 39.2%$7.4B
Where Every $100 of Revenue Goes (FY2026)
Cost of Revenue (COGS)$8.9B ($46.6 / $100)
R&D Reinvestment$812.0M ($4.3 / $100)
SG&A & Other OpEx$5.3B ($27.9 / $100)
Tax & Non-Operating$7.4B ($39.2 / $100)
Net Profit Kept$2.7B ($0.0 / $100)
Earnings Quality: GAAP Profit → True Owner Cash (FY2026)
GAAP Net Income$2.7B (14.2% margin)
Operating Cash Flow (OCF)$4.0B(21.0% of rev)
Less: Capital Expenditures−$443.0M(2.3% of rev)
Standard Free Cash Flow (FCF)$3.5B(18.6% margin)
Less: Stock-Based Comp (SBC)−$237.0M(6.7% of FCF)
True FCF (Owner Cash ex-SBC)$3.3B(17.4% of rev)

Operating leverage — margins

GrossOperatingNet
0%50%100%53%14%FY22FY23FY24FY25FY26
Unlocked SEC EDGAR Accounting Statements (USD)All 3 statements · Common-size (% of Revenue / Assets) · YoY growth · Tap any core row to explain
Line Item (USD)FY2022FY2023FY2024FY2025FY2026YoY Δ4Y CAGRTrend
Income Statement
Cost of Revenue (COGS)—$7.7B$8.6B$8.5B$8.9B+4.2%+4.6%
Research & Development (R&D)—$523.0M$781.0M$771.0M$812.0M+5.3%+15.8%
Selling, General & Admin (SG&A)—$4.2B$5.1B$5.1B$5.3B+3.8%+8.2%
Interest Expense————$147.0M——
Income Tax Expense—$642.0M$420.0M$690.0M$796.0M+15.4%+7.4%
Diluted Shares—577.3M574.0M566.7M562.0M−0.8%−0.9%
Balance Sheet
Cash & Equivalents$2.3B$8.1B$3.6B$1.5B$1.8B+17.0%−5.6%
Inventory$2.0B$2.0B$2.2B$2.2B$2.4B+9.9%+5.0%
Total Current Assets$9.0B$13.8B$10.2B$8.6B$9.5B+10.9%+1.4%
Total Assets$36.2B$42.7B$44.2B$42.0B$41.8B−0.4%+3.6%
Total Current Liabilities$8.2B$5.0B$5.7B$9.8B$10.1B+3.3%+5.5%
Total Debt (Short + Long Term)$10.0B$8.7B$8.2B$13.7B$12.9B−5.7%+6.8%
Stockholders' Equity$16.7B$26.6B$27.5B$20.3B$20.8B+2.3%+5.6%
Net Cash / (Net Debt)$-7.7B$-652.0M$-4.6B$-12.2B$-11.1B+8.6%—
Invested Capital$24.4B$27.3B$32.1B$32.5B$31.9B−1.8%+6.9%
Cash Flow & Capital Allocation
Depreciation & Amortization (D&A)—$1.1B$1.7B$1.5B$1.5B−2.6%+12.0%
Stock-Based Compensation (SBC)—$250.0M$260.0M$263.0M$237.0M−9.9%−1.8%
Capital Expenditures (CapEx)—$363.0M$419.0M$431.0M$443.0M+2.8%+6.9%
True FCF (ex-SBC Owner Cash)—$24.0M$2.7B$2.4B$3.3B+37.2%+416.0%
Share Repurchases (Buybacks)—$2.0B$435.0M$1.2B$1.0B−14.3%−20.6%
Dividends Paid—$1.2B$1.2B$1.2B$1.2B+4.4%+1.3%

Fundamentals, income distribution and multi-year statements from SEC EDGAR filings (public domain). Valuation multiples, performance and technicals computed from Databento 1D EOD closes. For information only, not investment advice.

On the Wire

what EMR did at the next close after each story

No Wire story has named EMR yet.

The Wire at 7 AM ET, free. Top stories with a bull and a bear case on each, every morning. No account needed.